Text Pad Main left last refresh: Print




** ALERT **




Flu Shots given in the Dining Room

Oct. 7th, 9th, 13th, and 17th

at 7 am - 8 am, 11 am - 2 pm, 6 pm - 8 pm. Our goal is 100% participation so please come get your FREE Flu shot and protect yourself.





Want to know more about CORE MEASURES?

JOIN our Core Measures Campaign!

Our objectives are to improve clinical outcomes

and achieve 100% compliance on core measures.


viewed in the Cafeteria NOW until Oct. 14th.


Core Measure Leaders will be in the Cafeteria

on Oct. 8th (Thursday) 11:30 am to 1:30 pm.


Sponsored by: Core Measures Lead Team/Munroe's Quality Dept.




"When we get enough people who don't care, and who don't accept personal responsibility for high ethical standards, our organization gets the "M" disease: Mediocrity. Anybody can be a carrier. By the same token, every individual can carry the cure: the ethics of excellence."

- Price Pritchett

 Each survey is confidential to the facility. Please help us by being candid in your answers.

Larry Field DO, MBA CMO


The link to the survey is:





Please review the policy in detail on the Home tab of the Portal. Click "Computerized Provider Order Entry Participation Policy". You can still schedule your one-on-one training with the Education Dept. by calling 351-7394 or x7394. 



Perioperative Bridging Anticoagulation in Atrial Fibrillation


The BRIDGE study, a randomized controlled trial, finds no benefit of bridging in reducing the risk of stroke or thromboembolism, but bridging increases bleeding.

(NEJM 2015;DOI:10.1056/NEJMoa1501035)


Custom Login last refresh: Print

Text Pad last refresh: Print

****** ALERT******


Beginning Tuesday, September 29, Tudorza and Spiriva inhalers will be substituted to ipratroprium  via nebulization q6h per MEC approval.  Thank You.

Text Pad - CM last refresh: Print

Important Information from the Blood Committee


A new series of articles will be posted on the Physician Portal to highlight various drugs and their management. One of the drugs highlighted in this article is Apixaban. For the entire article, login to Portal, click on the Home tab and look for the article, "Anticoagulants for Blood Mgmt  Comm NOV 18," a box will pop up giving you an opportunity to Open (to read) or Save/Save As (for future reading).


Apixaban (ELIQUIS)

Factor Xa inhibitor


For stroke prophylaxis and systemic embolus prevention in non-valvular a. fib:

                For most patients: 5 mg PO BID

                If SCr > 1.5 and age > 80 yr and/or wt < 60 kg: reduce dose to 2.5 mg PO bid

For DVT prophylaxis after knee or hip replacement surgery:

                For all patients: 2.5 mg PO BID x 12 days (knees)

                                                  2.5 mg PO BID x 35 days (hips) 

For DVT or PE treatment:

                10 mg PO BID x 7 days, then 5 mg PO BID for at least 6 months

For reduction in the risk of recurrent DVT and/or PE after completion of treatment for acute DVT or PE:  2.5 mg PO BID


Half-life: 9-12 hours


Message of the Day last refresh: Print
No content available.

Powered by McKesson HorzionWP Technology